Pfam Domains GO Terms
| PDGF |
| positive regulation of mast cell chemotaxis |
| vascular endothelial growth factor receptor binding |
| regulation of mast cell chemotaxis |
| induction of positive chemotaxis |
| vascular endothelial growth factor signaling pathway |
| positive regulation of positive chemotaxis |
| regulation of positive chemotaxis |
| chemoattractant activity |
| cellular response to vascular endothelial growth factor stimulus |
| branching involved in ureteric bud morphogenesis |
| positive chemotaxis |
| ureteric bud morphogenesis |
| mesonephric tubule morphogenesis |
| regulation of morphogenesis of a branching structure |
| sprouting angiogenesis |
| nephron tubule morphogenesis |
| nephron epithelium morphogenesis |
| vascular endothelial growth factor receptor signaling pathway |
| nephron morphogenesis |
| renal tubule morphogenesis |
| animal organ regeneration |
| nephron tubule development |
| renal tubule development |
| kidney morphogenesis |
| ureteric bud development |
| positive regulation of cell division |
| mesonephric tubule development |
| mesonephric epithelium development |
| positive regulation of leukocyte chemotaxis |
| mesonephros development |
| positive regulation of endothelial cell proliferation |
| nephron epithelium development |
| regulation of leukocyte chemotaxis |
| nephron development |
| positive regulation of leukocyte migration |
| regulation of endothelial cell proliferation |
| kidney epithelium development |
| branching morphogenesis of an epithelial tube |
| positive regulation of chemotaxis |
| regeneration |
| morphogenesis of a branching epithelium |
| growth factor activity |
| positive regulation of angiogenesis |
| morphogenesis of a branching structure |
| regulation of cell division |
| heparin binding |
| female pregnancy |
| positive regulation of vasculature development |
| positive regulation of epithelial cell proliferation |
| regulation of leukocyte migration |
| multi-multicellular organism process |
| regulation of chemotaxis |
| kidney development |
| renal system development |
| regulation of angiogenesis |
| epithelial tube morphogenesis |
| angiogenesis |
| urogenital system development |
| regulation of vasculature development |
| regulation of epithelial cell proliferation |
| response to hypoxia |
| response to decreased oxygen levels |
| response to oxygen levels |
| blood vessel morphogenesis |
| morphogenesis of an epithelium |
| blood vessel development |
| protein heterodimerization activity |
| positive regulation of cell migration |
| cellular response to growth factor stimulus |
| transmembrane receptor protein tyrosine kinase signaling pathway |
| vasculature development |
| cardiovascular system development |
| positive regulation of cell motility |
| response to growth factor |
| positive regulation of cellular component movement |
| chemotaxis |
| positive regulation of locomotion |
| taxis |
| tissue morphogenesis |
| positive regulation of response to external stimulus |
| cellular response to hormone stimulus |
| tube morphogenesis |
| enzyme linked receptor protein signaling pathway |
| tube development |
| regulation of cell migration |
| circulatory system development |
| protein homodimerization activity |
| anatomical structure formation involved in morphogenesis |
| response to hormone |
| regulation of cell motility |
| positive regulation of cell population proliferation |
| animal organ morphogenesis |
| regulation of locomotion |
| regulation of cellular component movement |
| multi-organism reproductive process |
| positive regulation of protein phosphorylation |
| response to drug |
| positive regulation of phosphorylation |
| regulation of anatomical structure morphogenesis |
| regulation of response to external stimulus |
| epithelium development |
| cell-cell signaling |
| positive regulation of phosphate metabolic process |
| positive regulation of phosphorus metabolic process |
| positive regulation of immune system process |
| response to abiotic stimulus |
| cellular response to endogenous stimulus |
| positive regulation of protein modification process |
| locomotion |
| positive regulation of developmental process |
| reproductive process |
| reproduction |
| regulation of protein phosphorylation |
| response to endogenous stimulus |
| regulation of phosphorylation |
| extracellular space |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| regulation of immune system process |
| positive regulation of protein metabolic process |
| positive regulation of multicellular organismal process |
| tissue development |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of protein modification process |
| extracellular region |
| membrane |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Methotrexate 0.01μM R08 exp501 | -2.44 |
| UM0129480 7μM R02 exp85 | 1.7 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution